Antifibrillatory drugs suppress ventricular fibrillation by blocking potassium channels on the outside of the cardiac membrane, reducing electrical inhomogeneities.
No takes yet. Share an insight, caveat, or question.
External IK blockade may reduce VF risk via repolarization homogeneity; leaves open clinical translation in humans.
Bacaner et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: